文献速递区域麻醉与超声疼痛医学

地塞米松加入局部浸润镇痛在全髋关节置换术中的双盲随机对照试验

Addition of dexamethasone to local infiltration analgesia in elective total hip arthroplasty: a double-blind, randomized control trial.
PubMed 文献 · Reg Anesth Pain Med · 2019-09-27

这项双盲随机对照试验纳入170例择期全髋关节置换术患者,比较局部浸润镇痛混合0.9%生理盐水2mL或地塞米松4mg/mL 2mL的效果。主要结局24小时口服吗啡消耗量两组相似,地塞米松组仅住院总阿片消耗量显著减少,术后恶心呕吐发生率降低,功能结局无差异。

要点

  • 地塞米松8mg加入局部浸润镇痛未减少全髋置换术后24小时吗啡消耗量。
  • 地塞米松组住院总阿片消耗量显著减少,但其他时间点无差异。
  • 地塞米松降低术后恶心呕吐发生率,对功能结局和长期镇痛无影响。

核心结论

  • 地塞米松8mg加入局部浸润镇痛未减少全髋关节置换术后24小时吗啡消耗量,但短期镇痛结局有限改善且术后恶心呕吐减少。
  • 地塞米松对功能结局或长期镇痛无影响。

研究设计与样本

  • 双盲随机对照试验,纳入170例择期全髋关节置换术患者,每组85例。
  • 患者随机接受局部浸润镇痛混合0.9%生理盐水2mL或地塞米松4mg/mL 2mL。
  • 主要结局为24小时口服吗啡消耗量,次要结局包括短期和长期镇痛与功能结局及不良事件。
  • 试验注册号NCT02760043。

主要发现

  • 24小时吗啡消耗量生理盐水组中位数(IQR(范围))为75(45-105(0-240))mg,地塞米松组为62.5(37.5-102.5(0-210))mg,p=0.145。
  • 地塞米松组住院总阿片消耗量显著减少,但其他检查时间点无显著差异。
  • 功能结局两组相似。
  • 地塞米松组术后恶心呕吐发生率降低。

临床怎么用

  • 全髋关节置换术局部浸润镇痛中加入地塞米松8mg不能期望减少24小时吗啡用量。
  • 地塞米松可能有助于减少住院期间总阿片消耗和术后恶心呕吐,但功能结局无改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Pain following total hip arthroplasty is significant, and effective analgesia is associated with an improvement in functional outcomes. Dexamethasone may facilitate the action of local anesthesia, but its role as an additive to a local infiltration analgesia (LIA) mixture in hip arthroplasty settings has not been investigated. We hypothesized that the addition of dexamethasone to local anesthetic infiltration improves analgesic outcomes following total hip arthroplasty. METHODS: We performed a double-blind, randomized control trial of 170 patients undergoing total hip arthroplasty. Patients were randomized to receive LIA mixed with either 2 mL of saline 0.9% or 2 mL of dexamethasone 4 mg/mL. The primary outcome was 24 hours oral morphine consumption. Secondary outcomes included short-term and long-term analgesic and functional outcomes and adverse events. RESULTS: 85 patients were included in each arm. 24 hours morphine consumption was similar between saline and dexamethasone groups, with a median (IQR (range)) of 75 (45-105 (0-240)) and 62.5 (37.5-102.5 (0-210)) mg, respectively (p=0.145). However, patients receiving dexamethasone had significantly reduced opioid consumption for their total in-hospital stay, but not at any other time points examined. Functional outcomes were similar between groups. The incidence of postoperative nausea and vomiting was reduced in patients receiving dexamethasone. CONCLUSIONS: The addition of 8 mg dexamethasone to LIA did not reduce 24 hours morphine consumption but was associated with limited improvement in short-term analgesic outcomes and a reduction in postoperative nausea and vomiting. Dexamethasone had no effect on functional outcomes or long-term analgesia. TRIAL REGISTRATION NUMBER: NCT02760043.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. El-Boghdadly K, Short AJ, Gandhi R, et al. Addition of dexamethasone to local infiltration analgesia in elective total hip arthroplasty: a double-blind, randomized control trial. Reg Anesth Pain Med. 2019. PMID: 31563881. doi:10.1136/rapm-2019-100873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。